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Abstract: Lymphomatoid granulomatosis is a rare Epstein barr virus associated lymphoma. It most commonly involves 
lungs, skin, central nervous system and kidneys. When lungs are involved, it often mimics common pulmonary 
conditions like pneumonia, making diagnosis extremely challenging. We present one such interesting case of 
Lymphomatoid granulomatosis in an immunocompetent young man.  
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INTRODUCTION 
Lymphomatoid granulomatosis(LYG) is an 
extremely rare lymphoproliferative process associated 
with Epstein barr virus infection. Lungs are almost 
always involved and pulmonary LYG is often confused 
for pneumonia and other common lung conditions 
posing a diagnostic conundrum. 
CASE DESCRIPTION 
In October 2012, a 28 year old perfectly healthy 
young man presented to a dermatologist with 
erythematous, raised, painful, circumscribed lesions 
over his left flank and left lateral chest wall. He was felt 
to have some kind of “contact dermatitis” and was 
prescribed topical steroids. Rash responded to steroids 
but returned shortly after stopping them. Besides the 
rash, he also reported a new symptom of non-
productive cough with mild dyspnea. He also started to 
develop fever, chills, night sweats, loss of appetite and 
unintentional weight loss. He was admitted to an 
outside hospital for further evaluation. 
A punch biopsy of skin lesion revealed 
granulomatous dermatitis. A chest radiograph revealed 
multiple masses involving both lungs, the largest of 
them involving right upper lobe, measuring 4.7 cm in its 
greatest diameter. A computerized tomography of 
chest confirmed the findings from the chest x-ray. No 
cavitation or calcification of these lesions was 
identified, and no pleural effusion or mediastinal 
lymphadenopathy was noted. A testicular ultrasound 
was performed which eliminated the possibility of 
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testicular cancer as the primary underlying malignancy. 
A CT-guided biopsy of the lung lesion revealed necrotic 
acellular material with negative bacterial, acid fast 
bacilli (AFB) and fungal cultures. Patient was empiri- 
cally treated with a five week course of antibiotics for 
presumed infection. Hepatitis B and C serologic testing 
and HIV screening were negative. Epstein Barr virus 
nuclear antigen (EBNA) IgG antibody titer was >8.0 
(<0.9 is negative) and EBV capsid antigen (EBV-VCA) 
IgG was >8.0 (<0.9 is negative), while EBV early 
antigen diffuse complex (Ea-D) was 0.8 (<0.9 is 
negative) and EBV-VCA IgM was <0.2 (<0.9 is 
negative). This EBV panel was interpreted to be 
consistent with past infection with Epstein Barr virus. A 
bone marrow aspiration and biopsy revealed 
normocellular marrow with no evidence of lymphoma 
on flow cytometry.  
After discharge from the hospital, he was evaluated 
by another dermatologist who performed a deep 
excisional biopsy of a skin lesion on his left lower back, 
which revealed dense lymphocytic infiltration with 
extensive CD3 positive T-cell infiltrate and few B-cells 
reminiscent of Reed-sternberg cells staining strongly 
for CD30, CD20 and LCA with rare CD15 positive cells. 
These findings were felt to be consistent with his 
previous diagnosis of ‘granulomatous dermatitis’. 
Three months into the diagnostic work up, the 
patient at this time presented to our lymphoma clinic for 
consultation. A repeat punch biopsy of skin and a 
wedge resection of left upper lobe lung lesion were 
performed. Skin biopsy was not informative. However, 
the lung biopsy was significant for atypical polymorphic 
lymphohistiocytic infiltrates with angiocentricity and 
necrosis. These atypical cells were positive for CD20, 
CD30, PAX5 and strongly positive for EBV encoded 
RNA on insitu hybridization (EBER-ISH). Numerous 
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CD2, CD3 positive T cells were found in the back- 
ground (Figure 1). The patient was diagnosed with 
lymphomatoid granulomatosis (LYG) grade 3.  
The patient was started on combination chemo 
immunotherapy with rituximab, etoposide, vincristine, 
cyclophosphamide and adriamycin (R-EPOCH). After 
completing six cycles, he had an excellent response 
initially with a dramatic improvement in his skin lesions 
as well as a complete resolution of his pulmonary 
symptoms. However, very shortly he developed 
respiratory distress requiring admission to intensive 
care unit showing worsening pulmonary findings on 
imaging studies and necrotic elements seen on 
broncho scope, along with worsening skin findings. 
Work up for infectious causes again has been negative 
and patient is currently started on a trial with interferon.  
DISCUSSION 
Lymphomatoid granulomatosis is a very rare 
angiodestructive lymphoproliferative disorder. It was 
first described by Liebow et al. in 1972 as an 
uncommon multi-organ systemic disease [1]. The 
World Health Organization classification in 2008 
described LYG as an extranodal, angiocentric, T-cell 
 
Figure 1: Histologic sections of the lung wedge biopsy demonstrate pulmonary parenchyma with an atypical lymphoistiocytic in 
filtrate encircling segmental areas of infarct-like necrosis. Foci with transmural vascular invasion and associated 
angiodestruction are present. (Fig. 1A and Fig. 1B: H&E stain) 
Variable numbers of CD20 positive B-cells (Fig. 1C: CD20 imunohistochemical stain) are identified admixed with in the infiltrate 
with abundant atypical EBV+ B –cells found palisading around the necrotic tumor and with in the vasculitic lesions (Fig. 1D: in 
situ hybridization for EBV-encoded RNA). EBER+ cells were enumerated at >50 per high power field (LYG, grade 3). 
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rich B-cell lymphoma and placed it under the category 
of “Large B-cell Lymphomas”[2]. It is an EBV driven 
lymphoproliferative process. Lungs are almost always 
involved and the other common sites of involvement 
are skin, central nervous system and kidneys [3, 4]. 
Lymphoid organs and spleen are usually spared at the 
time of diagnosis [3, 4]. Pulmonary LYG mimics the 
common pulmonary conditions like pneumonia, and the 
distinction between them can be extremely difficult as 
LYG is not routinely considered in the initial differential 
diagnoses [5]. Cutaneous manifestations are quite 
variable from erythematous maculopapular eruptions to 
subcutaneous nodules that may ulcerate and 
sometimes, may present as indurated plaques. As 
seen in our patient, skin biopsies usually lack the 
abnormal EBV positive B-cells making the diagnosis 
extremely challenging. However, lung biopsies are 
typically diagnostic [4, 5]. Serological testing for EBV 
has been found to be positive in almost all the cases.  
Histological features of polymorphic lymphocytic 
infiltrate, angiocentricity and marked transmural 
infiltration of the blood vessels, along with varying 
degree of central necrosis are required for the definitive 
diagnosis of LYG [3] Based on the proportion of EBV 
positive B cells, LYG is divided into three grades [3, 4]. 
There is no standard therapeutic approach to this 
lymphoma. However, the study from the NCI 
recommends using interferon alpha-2b for low grade 
LYG (grade 1 and 2) and dose adjusted R-EPOCH for 
high grade (grade 3) LYG [4, 6].  
 
CONCLUSION 
Lymphomatoid granulomatosis is an extremely rare 
EBV driven lymphoproliferative disease with multi-
organ involvement. Diagnosis is often a big challenge, 
firstly because of its close resemblance to many 
common diseases, and secondly because physicians 
often do not consider LYG in their initial differential 
diagnoses and therefore, fail to look for EBV serology 
or EBV-ISH on biopsies. Skin biopsies are not always 
diagnostic and lung biopsies should be obtained in 
such cases. Patients with low grade LYG can be 
observed for regression and interferon-alpha-2b can be 
used to enhance the host’s immune system. High 
grade LYG should be treated immediately with 
combination chemotherapy and rituximab, similar to 
those used in diffuse large B cell lymphoma.  
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